Brief Depression Screener Developed Using IRT for Antenatal and Postpartum Women

使用 IRT 为产前和产后妇女开发简短的抑郁症筛查仪

• 批准号: 7715036
• 负责人: BENJAMIN B BRODEY
• 金额: $ 42.81万
• 依托单位: TELESAGE, INC.
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-05-15 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7715036
• 关键词: Address; Anxiety; Area; Beck depression inventory; Caring; Child; Clinic; Clinical; Cognitive; Confusion; Data; Data Analyses; Development; Event; Family; Goals; Gold; Grant; Health; Health Care Visit; Hyperactive behavior; Information Systems; Interview; Language; Length; Life; Light; Measurement; Measures; Mental Health; Mental Health Services; Modeling; National Institute of Mental Health; Outcome; Patient Outcomes Assessments; Perinatal; Phase; Physicians; Postpartum Depression; Postpartum Women; Pregnancy; Private Sector; Problem behavior; Process; Psychopathology; Public Sector; Recommendation; Recruitment Activity; Research; Research Personnel; Risk; Sampling; Scotland; Screening procedure; Services; Site; Small Business Innovation Research Grant; Structure; Surveys; Symptoms; Technology; Testing; Time; United States; Validation; Visit; Woman; base; depressed; depression; depressive symptoms; experience; high risk; improved; inattention; instrument; interest; maternal depression; men; phrases; pregnant; programs; psychologic; public health relevance; response; satisfaction; sound; success

DESCRIPTION (provided by applicant): Estimates of antenatal and postpartum depression vary from 7 percent to upwards of 30 percent depending on criteria for depression, the type of assessment used, and the timing of the assessment. Thus, approximately 320,000 to over 1 million women each year experience symptoms of perinatal depression. Estimates of antenatal depression are harder to obtain because of the lack of appropriate diagnostic criteria. Despite this, no screener currently exists that has been developed and tested with both antenatal and postpartum women that uses concise, simple language, and a consistent response option set. The overall aim of this project is to develop a brief screener to assess depressive symptoms among antenatal and postpartum women. The proposed screener will be easier for patients to understand, will take less time, and will be more psychometrically sound than current screeners. In Phase I we will develop approximately 30 items that are specific to depression in antenatal and postpartum women. We will test these items using cognitive interviewing among a sample of 10 antenatal and 10 postpartum women in addition to 32 general depression items we have previously developed. Experts will review the results of the cognitive interviewing to develop the item pool that will be tested in Phase II. The Phase II item pool will consist of at least 20 general depression items, 10 items specific to antenatal women, and 10 items specific to postpartum women. In Phase II, 500 antenatal and 500 postpartum women (70 percent from private sector sites and 30 percent from public sector sites) will complete the EPDS (as a screener into the study), BDI-II, the PROMIS depression items, our items, and the depression module of the SCID. IRT analyses will be conducted on these data to develop a 7-9 item screener. We anticipate that approximately 5-7 of these items will be applicable to both antenatal and postpartum women and approximately 2-3 of these items will be sample specific. The developed screener will then be given to 400 women who will take the survey twice, approximately 4-7 days apart. Conclusions regarding test-retest reliability and patient satisfaction with taking the screener using different modes of technologies will be made from this study.

描述（由申请人提供）：产前和产后抑郁症的估计值从7%到30%不等，这取决于抑郁症的标准，使用的评估类型和评估的时间。因此，每年约有32万至100多万妇女经历围产期抑郁症的症状。由于缺乏适当的诊断标准，产前抑郁症的估计更难获得。尽管如此，目前还没有一种筛查工具是在产前和产后妇女中开发和测试的，它使用简洁、简单的语言和一致的反应选项集。该项目的总体目标是开发一个简短的筛选器，以评估产前和产后妇女的抑郁症状。拟议中的筛选器将更容易为患者理解，将需要更少的时间，并将更多的心理测量声音比目前的筛选器。在第一阶段，我们将开发大约30个项目，专门针对产前和产后妇女的抑郁症。我们将测试这些项目使用认知访谈的样本中的10个产前和10个产后妇女除了32个一般抑郁症的项目，我们以前开发的。专家将审查认知访谈的结果，以开发将在第二阶段测试的项目库。第二阶段项目库将包括至少20个一般抑郁症项目，10个产前妇女专用项目和10个产后妇女专用项目。在第二阶段，500名产前和500名产后妇女（70%来自私营部门，30%来自公共部门）将完成EPDS（作为研究的筛选），BDI-II，PROMIS抑郁项目，我们的项目和SCID的抑郁模块。将对这些数据进行IRT分析，以开发7-9项筛选器。我们预计，这些项目中约有5-7项将适用于产前和产后妇女，其中约有2-3项将是样本特异性的。然后，将开发的筛选器提供给400名女性，她们将接受两次调查，大约间隔4-7天。本研究将得出关于使用不同技术模式服用筛选剂的重测信度和患者满意度的结论。